Market Overview

UPDATE: Deutsche Bank Upgrades LifePoint Hospitals on Move to More Constructive Stance


In a report published Thursday, Deutsche Bank analyst Darren Lehrich upgraded the rating on LifePoint Hospitals (NASDAQ: LPNT) from Hold to Buy, and raised the price target from $56.00 to $61.00.

In the report, Deutsche Bank noted, “We are moving to a more constructive stance on LPNT shares, and taking our PT to $61 (from $56). Our Buy rating (from Hold) and positive investment case are underpinned by DB's view that: (1) LPNT's M&A pipeline offers more tailwinds vs. headwinds, while also providing a credible EBITDA bridge to beat 2014 consensus. (2) LPNT could re-leverage moderately over the N-T, thus setting-up more accretive capital deployment vs. expectations. (3) LPNT's geographic footprint is more favorably exposed to Medicaid expansion states vs. many peers, thus setting-up N-T visibility in the context of the early PPACA exchange glitches. BUY rating better reflects more favorable stance on LPNT.”

LifePoint Hospitals closed on Wednesday at $50.93.

Latest Ratings for LPNT

Jul 2018MaintainsNeutralNeutral
Jul 2018MaintainsMarket PerformMarket Perform
Jul 2018DowngradesOutperformNeutral

View More Analyst Ratings for LPNT
View the Latest Analyst Ratings

Posted-In: Darren Lehrich Deutsche BankAnalyst Color Upgrades Analyst Ratings


Related Articles (LPNT)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Piper Jaffray Reiterates on Fossil Group as Proprietary Holiday Analysis Suggests Jewelry Momentum Could Continue

Tower Group to Restate Financial Statements